• CARDIOVASCULAR | Dr. Larry R. Jackson, II | Promoting Health Equity in Atrial Fibrillation Management

  • 2023/12/04
  • 再生時間: 25 分
  • ポッドキャスト

CARDIOVASCULAR | Dr. Larry R. Jackson, II | Promoting Health Equity in Atrial Fibrillation Management

  • サマリー

  • Despite having a lower reported prevalence of atrial fibrillation, contemporary data suggest underrepresented racial and ethnic populations experience disparities in atrial fibrillation treatment and health outcomes. Join our MSL co-hosts Dalila Masic, PharmD and Teresa Russell, PharmD as they have a conversation with Larry R. Jackson, II, MD, MHSc. What does the literature show about atrial fibrillation detection, management, and outcomes in underrepresented populations with atrial fibrillation? How can clinicians partner with patients to help bridge these gaps? Dr. Jackson shares his insights from years of clinical experience and research on health equity and racial/ethnic differences in arrhythmia care.

    This program is non-promotional and sponsored by Sanofi. The presenter was compensated by Sanofi in connection with this program. This program does not constitute an endorsement by Sanofi of any particular organization or its programming. Additional resources and information may be available and should be investigated.

    Resources mentioned in episode:

    1. American College of Cardiology CardioSmart Tools: https://www.cardiosmart.org/topics/atrial-fibrillation

    2. Healthwise Shared Decision Making Tools: https://www.healthwise.org/solutions/care-transformation.aspx


    Supporting literature from episode:

    1. Racial and Ethnic Considerations in Patients with Atrial Fibrillation: JACC Focus Seminar 5/9: https://pubmed.ncbi.nlm.nih.gov/34887142/

    2. Racial/Ethnic Differences in Atrial Fibrillation Symptoms, Treatment Patterns, and Outcomes: Insights from Outcomes Registry for Better Informed Treatment for Atrial Fibrillation Registry: https://pubmed.ncbi.nlm.nih.gov/26995367/

    3. Differences by Race/Ethnicity in the Prevalence of Clinically Detected and Monitor-Detected Atrial Fibrillation: MESA: https://pubmed.ncbi.nlm.nih.gov/31934795/

    4. Ablation Versus Drug Therapy for Atrial Fibrillation in Racial and Ethnic Minorities: https://pubmed.ncbi.nlm.nih.gov/34238436/

    5. Under-Reporting and Under-Representation of Racial/Ethnic Minorities in Major Atrial Fibrillation Clinical Trials: https://doi.org/10.1016/j.jacep.2020.03.001

    6. Racial and Ethnic Disparities in Arrhythmia Care: A Call for Action: https://pubmed.ncbi.nlm.nih.gov/35842408/


    Music: Spark of Inspiration by Shane Ivers - https://www.silvermansound.com

    This program is non-promotional and sponsored by Sanofi. Presenter(s) were compensated and/or received an honorarium from Sanofi in connection with this program. This program does not constitute an endorsement by Sanofi of any particular organization or its programming. Additional resources and information may be available and should be investigated.

    This podcast is intended for US residents only. Sanofi does not provide medical advice, diagnosis, or treatment. The health information contained herein is provided for general educational purposes only. Your healthcare professional is the best source of information regarding your health. Please consult your healthcare professional if you have any questions about your health or treatment.

    続きを読む 一部表示

あらすじ・解説

Despite having a lower reported prevalence of atrial fibrillation, contemporary data suggest underrepresented racial and ethnic populations experience disparities in atrial fibrillation treatment and health outcomes. Join our MSL co-hosts Dalila Masic, PharmD and Teresa Russell, PharmD as they have a conversation with Larry R. Jackson, II, MD, MHSc. What does the literature show about atrial fibrillation detection, management, and outcomes in underrepresented populations with atrial fibrillation? How can clinicians partner with patients to help bridge these gaps? Dr. Jackson shares his insights from years of clinical experience and research on health equity and racial/ethnic differences in arrhythmia care.

This program is non-promotional and sponsored by Sanofi. The presenter was compensated by Sanofi in connection with this program. This program does not constitute an endorsement by Sanofi of any particular organization or its programming. Additional resources and information may be available and should be investigated.

Resources mentioned in episode:

1. American College of Cardiology CardioSmart Tools: https://www.cardiosmart.org/topics/atrial-fibrillation

2. Healthwise Shared Decision Making Tools: https://www.healthwise.org/solutions/care-transformation.aspx


Supporting literature from episode:

1. Racial and Ethnic Considerations in Patients with Atrial Fibrillation: JACC Focus Seminar 5/9: https://pubmed.ncbi.nlm.nih.gov/34887142/

2. Racial/Ethnic Differences in Atrial Fibrillation Symptoms, Treatment Patterns, and Outcomes: Insights from Outcomes Registry for Better Informed Treatment for Atrial Fibrillation Registry: https://pubmed.ncbi.nlm.nih.gov/26995367/

3. Differences by Race/Ethnicity in the Prevalence of Clinically Detected and Monitor-Detected Atrial Fibrillation: MESA: https://pubmed.ncbi.nlm.nih.gov/31934795/

4. Ablation Versus Drug Therapy for Atrial Fibrillation in Racial and Ethnic Minorities: https://pubmed.ncbi.nlm.nih.gov/34238436/

5. Under-Reporting and Under-Representation of Racial/Ethnic Minorities in Major Atrial Fibrillation Clinical Trials: https://doi.org/10.1016/j.jacep.2020.03.001

6. Racial and Ethnic Disparities in Arrhythmia Care: A Call for Action: https://pubmed.ncbi.nlm.nih.gov/35842408/


Music: Spark of Inspiration by Shane Ivers - https://www.silvermansound.com

This program is non-promotional and sponsored by Sanofi. Presenter(s) were compensated and/or received an honorarium from Sanofi in connection with this program. This program does not constitute an endorsement by Sanofi of any particular organization or its programming. Additional resources and information may be available and should be investigated.

This podcast is intended for US residents only. Sanofi does not provide medical advice, diagnosis, or treatment. The health information contained herein is provided for general educational purposes only. Your healthcare professional is the best source of information regarding your health. Please consult your healthcare professional if you have any questions about your health or treatment.

CARDIOVASCULAR | Dr. Larry R. Jackson, II | Promoting Health Equity in Atrial Fibrillation Managementに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。